Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Advisorshares Pure US Cannabis ETF (NY: MSOS )

4.500 +0.050 (+1.12%)
Streaming Delayed Price Updated: 11:01 AM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Advisorshares Pure US Cannabis ETF

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Largest American Cannabis MSO Stock Prices For Week Ending June 16th
The 7 largest multi-state cannabis operators in the U.S., as tracked in our American Cannabis MSOs Index, were stable last week declining only 0.6%, on average, and are now down only 1.9%, on average,... 
Via Talk Markets
Majority of American MSOs Down MTD, Again, Led By Trulieve
Six of the 7 largest multi-state operators of cannabis companies in the U.S., as tracked in our American Cannabis MSOs Index, are down YTD, and 4 of the 7 are also down MTD. The ETF, MSOS, isn't doing... 
Via Talk Markets
May Summary Of Largest American Cannabis MSO Stock Performances
The American Cannabis MSOs Index was down 0.9% in May and is now down 18.9% YTD. 
Via Talk Markets
3 New Cannabis Stock Risks Are Emerging -- As If There Aren't Enough Already
These issues don't make the industry hopeless but could make the complex path even more difficult. 
Via The Motley Fool
Largest U.S. Cannabis Stocks Continue To Outperform Canadian LPs
The 7 constituents in the munKNEE American Cannabis MSOs Index are UP 11.7% MTD, on average, but are still DOWN 8.6% YTD and have an average Wall Street analyst 12-month price target representing a... 
Via Talk Markets
Is Curaleaf a Buy?
With a toxic cocktail of the market and economic factors in play, it's a risky bet. 
Via The Motley Fool
ETFs Outperforming The S&P 500, On Average
If you are bullish on any of the cannabis, psychedelic, cryptocurrency, or gold and silver junior miner categories then consider buying these six ETFs. 
Via Talk Markets
Business Events In Miami, Florida This Week: Cannabis Conference, Psychedelics Investment And Science Summit, Lexy Panterra And More
Are you looking for events in Miami, Florida this week? Look no further! 
Via Benzinga
"Multi-Bagger" Portfolio Down 13% In March; Still Up Almost 6% YTD
The 
Via Talk Markets
Our Aggressive ETF Portfolio Is Outperforming The S&P 500 By A 2-To-1 Margin
Our Aggressive ETF Portfolio consists of 6 ETFs containing some downtrodden categories: cannabis MSOs and LPs, psychedelic stocks, cryptocurrency futures, and junior gold and silver miners. 
Via Talk Markets
Down 80% in 1 Year, Is SNDL Stock Ready for a Bull Run?
Canadian cannabis company SNDL is looking more appealing by the quarter. 
Via The Motley Fool
An Aggressive ETF Portfolio For 2023: An Update
If you are bullish on any of the cannabis, psychedelic, cryptocurrency, or gold and silver junior miner categories, take a look at these ETFs. 
Via Talk Markets
The "Multi-Bagger" Portfolio: An Update
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 - DOWN 73% vs. 2021 - but perhaps some of them will bounce back with major - dare I say 
Via Talk Markets
3 Cannabis Stocks to Buy and Hold for the Next 10 Years
These three growth stocks provide some of the best exposure to this potentially explosive sector. 
Via The Motley Fool
An Aggressive ETF Portfolio For 2023
If you are bullish on any of the cannabis, psychedelic, cryptocurrency or gold and silver junior miner categories you might want to buy one or more of the ETFs highlighted in this article. 
Via Talk Markets
These 8 Cannabis Portfolio Performances Range From +/-0% To -12% YTD
8 portfolios, consisting exclusively of cannabis and cannabis-related stocks, are all over the map ranging from +/-0% YTD to -12% YTD. 
Via Talk Markets
"Rags-To-Riches" Portfolio Outpacing S&P 500 By 2-To-1 Margin
The 
Via Talk Markets
"Multi-Bagger" Portfolio Outperforming "Rags-To-Riches" Portfolio By 2-To-1 Margin YTD
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022 but perhaps some will bounce back with 
Via Talk Markets
"Multi-Bagger" Portfolio Outperforming "Rags-To-Riches" Portfolio YTD By A 2-To-1 Margin
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022. Perhaps some will bounce back with 
Via Talk Markets
Forget $4 Billion. Analysts Don't See Tilray Even Getting to $1 Billion Anytime Soon
Could this beaten-down stock make for a good contrarian buy? 
Via The Motley Fool
2 ETFs Added To Best Cannabis Portfolio Performance Competition
With the addition of the 2 cannabis ETFs, there are now 8 portfolios competing for the highest returns this year in cannabis stocks. Their performances have ranged from No Change YTD to an impressive... 
Via Talk Markets
2 Cannabis Stocks You Can Buy and Hold for the Next Decade
Focus on companies that have already shown their ability to make a profit. 
Via The Motley Fool
Should Cannabis Investors Be Starting to Sweat?
Even some of the industry's stalwarts are showing signs of stress. 
Via The Motley Fool
3 Cannabis Stocks to Buy and Hold for the Next 10 Years
All of these companies are trading at low price-to-book-value ratios. 
Via The Motley Fool
3 Chilling Headwinds Coming for Cannabis Stocks in 2023
If you thought 2022 was harsh, just wait. 
Via The Motley Fool
Top And Flop ETFs Of 2022
Given the market turmoil of 2022, which included significant events such as the collapse of crypto empires and bond market tantrums, I have highlighted ETFs from the best and worst performing zones of... 
Via Talk Markets
Can Stocks Buck The Rising Odds Of A Recession?
The S&P 500 rose 1.1% and ended the week above its 200-day moving average. Fed Chair Powell spurred a strong rally in stocks on Wednesday, saying interest rates could rise less in December compared to... 
Via Talk Markets
3 Best Marijuana Stocks to Buy in December
All three are pursuing strategies that are working and will work even better in the long term. 
Via The Motley Fool
What Makes Upside Potential For Hexo? Analyst Explains On Heels Of The Deal Break With Molson Coors
Year-to-date, Hexo (NASDAQ: HEXO) shares lost 77.15%, compared to AdvisorShares Pure Cannabis ETF (NYSEARCA: YOLO) which went down 61.12%, and AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS), which... 
Via Benzinga
2 Marijuana Stocks That Could Be the Best Bargains of 2023
These stocks may not stay this cheap for long. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.